DeepMed Research

BANC DE SANG I TEIXITS

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Established: 1995-01-01

Employees: 501

Market Cap: -

Website: http://www.bancsang.net

Clinical Trials

Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury

Phase 1

Completed

Conditions: Spinal Cord Injury Cervical

Interventions: Drug: Placebo
Drug: WJ-MSC (XCEL-UMC-BETA)

First Posted Date: 2021-09-23

Last Posted Date: 2024-01-24

Lead Sponsor: Banc de Sang i Teixits

Target Recruit Count: 18

Registration Number: NCT05054803

Locations: 🇪🇸
Complexo Hospitalario Universitario A Coruña (CHUAC), A Coruña, Spain
🇪🇸
Hospital de Neurorehabilitació Institut Guttmann, Badalona, Barcelona, Spain

Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19

Phase 1

Completed

Conditions: COVID-19
SARS-CoV 2
Adult Respiratory Distress Syndrome

Interventions: Drug: XCEL-UMC-BETA
Other: Placebo

First Posted Date: 2020-05-15

Last Posted Date: 2023-01-26

Lead Sponsor: Banc de Sang i Teixits

Target Recruit Count: 26

Registration Number: NCT04390139

Locations: 🇪🇸
Mútua de Terrassa, Terrassa, Barcelona, Spain
🇪🇸
Hospital Vall d'Hebron, Barcelona, Spain
🇪🇸
Hospital Clínic de Barcelona, Barcelona, Spain

and more 2 locations

Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

Phase 1

Completed

Conditions: CMV Viremia
Immunosuppression-related Infectious Disease

Interventions: Drug: Activated T-Lymphocytes

First Posted Date: 2019-07-12

Last Posted Date: 2024-01-24

Lead Sponsor: Banc de Sang i Teixits

Target Recruit Count: 26

Registration Number: NCT04018261

Locations: 🇪🇸
Hospital Vall d'Hebron, Barcelona, Spain
🇪🇸
Hospital Sant Joan de Déu, Esplugues De Llobregat, Barcelona, Spain
🇪🇸
Hospital Clinic i Provincial de Barcelona, Barcelona, Spain

and more 4 locations

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.

Phase 1

Completed

Conditions: Polytrauma
Traumatic Hemorrhage

Interventions: Drug: Fibrinogen Concentrate (Human) 1 MG [RiaSTAP]
Biological: Red blood cells concentrate
Drug: Tranexamic Acid

First Posted Date: 2018-12-19

Last Posted Date: 2024-01-25

Lead Sponsor: Banc de Sang i Teixits

Target Recruit Count: 79

Registration Number: NCT03780894

Locations: 🇪🇸
Hospital Josep Trueta, Girona, Spain

A Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy

Phase 1

Terminated

Conditions: Neurotrophic Keratopathy

Interventions: Drug: Cord Blood Eye Drops
Drug: Conventional treatment

First Posted Date: 2017-03-21

Last Posted Date: 2020-10-27

Lead Sponsor: Banc de Sang i Teixits

Target Recruit Count: 9

Registration Number: NCT03084861

Locations: 🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain
🇪🇸
Hospital Joan XXIII, Tarragona, Spain
🇪🇸
Institut de microcirurgia ocular IMO, Barcelona, Spain

and more 7 locations

Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury

Phase 1

Completed

Conditions: Spinal Cord Injury, Chronic

Interventions: Drug: XCEL-UMC-BETA
Drug: Placebo

First Posted Date: 2016-12-28

Last Posted Date: 2020-02-17

Lead Sponsor: Banc de Sang i Teixits

Target Recruit Count: 10

Registration Number: NCT03003364

Locations: 🇪🇸
Hospital de Neurorehabilitació Institut Guttmann, Badalona, Barcelona, Spain

Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture

Phase 1

Withdrawn

Conditions: Femoral Neck Fracture

Interventions: Drug: XCEL-MT-OSTEO-BETA
Procedure: Surgical treatment

First Posted Date: 2015-12-15

Last Posted Date: 2017-03-17

Lead Sponsor: Banc de Sang i Teixits

Registration Number: NCT02630836

Autologous Mesenchymal Stromal Cells for Multiple Sclerosis

Phase 1

Completed

Conditions: Relapsing-Remitting Multiple Sclerosis
Secondary Progressive Multiple Sclerosis

Interventions: Drug: XCEL-MC-ALPHA
Drug: Placebo

First Posted Date: 2015-07-13

Last Posted Date: 2020-01-21

Lead Sponsor: Banc de Sang i Teixits

Target Recruit Count: 8

Registration Number: NCT02495766

Locations: 🇪🇸
Hospital Vall Hebron, Barcelona, Spain

Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation

Phase 1

Completed

Conditions: Leukemia

Interventions: Drug: DLI of the 20 fraction of the UCBT

First Posted Date: 2014-12-31

Last Posted Date: 2021-12-08

Lead Sponsor: Banc de Sang i Teixits

Target Recruit Count: 17

Registration Number: NCT02328885

Locations: 🇪🇸
Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸
Hospital de Sant Pau, Barcelona, Spain
🇪🇸
Hospital Vall Hebron, Barcelona, Spain

and more 1 locations

Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones

Phase 1

Completed

Conditions: Atrophic Nonunion of Fracture

Interventions: Drug: XCEL-MT-OSTEO-ALPHA
Other: autologous iliac crest
Procedure: Surgery

First Posted Date: 2014-09-03

Last Posted Date: 2021-04-12

Lead Sponsor: Banc de Sang i Teixits

Target Recruit Count: 19

Registration Number: NCT02230514

Locations: 🇪🇸
Hospital ASEPEYO Sant Cugat, Sant Cugat, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy